Advertisement

Topics

MYCOPLASMA EXPERIENCE LIMITED Company Profile

07:43 EDT 23rd June 2018 | BioPortfolio

The Company was founded in 1988 by David and Helena Windsor, both ex-employees of Wellcome Research Laboratories, whose careers had centred on benchwork with mycoplasmas covering Production, Quality Control and Research and Development.Privately owned and independent, Mycoplasma Experience is concerned solely with mycoplasmas and closely related organisms.

Contact

Phone: (44) 1737 226662
Fax: (44) 1737 224751
Email: mexp@mycoplasma-exp.com


News Articles [163 Associated News Articles listed on BioPortfolio]

Synthetic Vaccines

In 2010 scientists from the JCVI announced the creation of the first bacterial cell controlled by a chemically synthesized genome1. The ‘synthetic’ cell was mycoplasma, a bacterium with an excepti...

Thermo Fisher mycoplasma detection tech accepted for cell therapies

Thermo Fisher Scientificâs mycoplasma detection kit has been accepted by regulators for quality assurance, quality control and lot release.

Global Mycoplasma Diagnostics Market Country Shares and Segment Forecasts 20172021: Emerging Opportunities and Growth Strategies for Suppliers [Report Updated: 03012018] Prices from USD $4350

The report presents a detailed analysis of the Mycoplasma diagnostics market in the US, Europe France, Germany, Italy, Spain, UK and Japan. Current scientific views on the Mycoplasma definition, epid...

Method to Remove Mycoplasma Contamination from Virus Stocks

Mycoplasma are a form of bacteria that are commonly found as contaminants in cell cultures. They adversely affect cell line growth rates and viral vaccine production. Mycoplasma contamination is a cha...

Pending EC decision: Porcilis PCV M Hyo, porcine circovirus and Mycoplasma hyopneumoniae vaccine (inactivated), Opinion date: 25-May-2018

Merck launches filters to protect against bioreactor contamination

New Viresolve barrier capsule filters are designed to remove viruses, mycoplasma and bacteria from cell culture media

Rapid Mycoplasma Testing Method Now Accepted By Regulators

NewsFollowing validation, regulatory review, and acceptance, the company's MycoSEQ assay and method can be used for lot release by manufacturers in different therapeutic modalities, including biothera...

Mycoplasma Testing Market Grows Due to Increasing Focus on R&D of Biopharmaceuticals | Technavio

Technavio market research analysts have predicted the global mycoplasma testing market to grow at a CAGR of mo

PubMed Articles [781 Associated PubMed Articles listed on BioPortfolio]

Isolation of Mycoplasma spp. and serological responses in bulls prior to and following their introduction into Mycoplasma bovis-infected dairy herds.

With the common use of bulls for breeding following a period of artificial insemination in seasonally bred dairy herds, it is important to consider the potential role of the bull in transmission of My...

Loop-Mediated Isothermal Amplification on Crude DNA as a Point-of-Care Test for the Diagnosis of Mycoplasma-Related Vaginitis During Early Pregnancy.

Mycoplasma-related vaginitis gradually has been growing as a threat in adults-genitourinary infection contributes to funisitis, spontaneous abortion, and low birth weight. Until now, use of loop-media...

Prevalence of Mycoplasma genitalium and Azithromycin-Resistant Infections Among Remnant Clinical Specimens, Los Angeles.

Mycoplasma genitalium is an important cause of bacterial sexually transmitted diseases. Diagnosis and susceptibility testing of Mycoplasma genitalium are limited by the fastidious nature of the organi...

Evaluation of effects of Mycoplasma mastitis on milk composition in dairy cattle from South Australia.

Mycoplasma mastitis is increasingly posing significant impact on dairy industry. Although the effects of major conventional mastitis pathogens on milk components has been widely addressed in the liter...

Tuberculous pleurisy mimicking Mycoplasma pneumoniae infection in a previously healthy young adult: A case report.

Sometimes, pleural effusion accompanying an acute Mycoplasma pneumoniae infection or tuberculous pleurisy has similar analysis results. We report a case of tuberculous pleurisy which was initially dia...

Clinical Trials [1404 Associated Clinical Trials listed on BioPortfolio]

Detection of Mycoplasma Pneumoniae

The objective of this Clinical Trial is to define the methods to be used to document that illumigene® Mycoplasma Direct meets its intended use claims, using the illumipro instrument, with...

Treatment of Macrolide-resistant Mycoplasma Pneumoniae

A randomized clinical trial comparing treatment effectiveness of azithromycin and doxycycline for pediatric Mycoplasma pneumonia.

Chlamydia and Mycoplasma in Coronary Artery Disease

To test the association between anti-Chlamydia serum titers and anti-Mycoplasma antibodies with Acute Coronary Syndromes.

Prevalence and Clinical Significance of co-Infection of Mycoplasma Pneumoniae in Patients With Pulmonary Tuberculosis

Several case report showed that the co-infection of Mycoplasma pneumoniae in patients with pulmonary tuberculosis. The aim of this study is to elucidate the prevalence and its clinical sig...

Effects of Oral Steroid in Mycoplasma Pneumoniae Pneumonia

Mycoplasma pneumoniae is one of the most common causes of community-acquired pneumonia in children. The clinical course is typically self-limited and benign; however, rare cases of severe ...

Companies [584 Associated Companies listed on BioPortfolio]

MYCOPLASMA EXPERIENCE LIMITED

The Company was founded in 1988 by David and Helena Windsor, both ex-employees of Wellcome Research Laboratories, whose careers had centred on benchwork with mycoplasmas covering Production, Quality C...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

VASUDHA PHARMA CHEM LIMITED

VASUDHA PHARMA CHEM LIMITED (VPCL) is a Company promoted by a team of accomplished technocrats for Bulk Drug industry with a total capital of Rupees 153 million ( US $ 5Million).All the promoters of V...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

TEXCELL

TEXCELL, a spin-off company of the Pasteur Institute, is based in Evry Genopole in more than 16,000 sq. ft of offices and BSL2/BSL3 laboratory facilities. TEXCELL offers GLP/GMP compliant services...

More Information about "MYCOPLASMA EXPERIENCE LIMITED" on BioPortfolio

We have published hundreds of MYCOPLASMA EXPERIENCE LIMITED news stories on BioPortfolio along with dozens of MYCOPLASMA EXPERIENCE LIMITED Clinical Trials and PubMed Articles about MYCOPLASMA EXPERIENCE LIMITED for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MYCOPLASMA EXPERIENCE LIMITED Companies in our database. You can also find out about relevant MYCOPLASMA EXPERIENCE LIMITED Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record